IFP Advisors, Inc - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 17 filers reported holding IMMUNE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$010.0%0.00%
Q2 2017$010.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Virtu Financial LLC 24,681$14,0000.00%
Steward Partners Investment Advisory, LLC 250$00.00%
BANK OF AMERICA CORP /DE/ 21,594$12,0000.00%
UBS Group AG 87,514$50,0000.00%
CREDIT SUISSE AG/ 23,504$14,0000.00%
Advisor Group, Inc. 3,750$2,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 22,355$12,0000.00%
BlackRock Inc. 568$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,251$8,0000.00%
JPMORGAN CHASE & CO 11,510$7,0000.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders